Last update 01 Nov 2024
Tibotec Pharmaceuticals
Subsidiary Company|
Ireland
Last update 01 Nov 2024
Overview
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
评价TMC435 100及150mg q.d.多次口服给药用于中国健康受试者的药代动力学、安全性和耐受性的I期、开放性研究
[Translation] A Phase I, open-label study to evaluate the pharmacokinetics, safety, and tolerability of TMC435 100 and 150 mg q.d. multiple oral doses in healthy Chinese subjects
TMC435、聚乙二醇干扰素α-2a和利巴韦林用于未经治疗基因1型慢性丙肝的疗效、药动学、安全和耐受性研究
[Translation] Efficacy, pharmacokinetics, safety and tolerability of TMC435, peginterferon alfa-2a and ribavirin in treatment-naïve chronic hepatitis C genotype 1
A Phase III, randomized, double-blind trial to evaluate the efficacy, safety and tolerability of TMC435 vs. telaprevir, both in combination with PegIFN?-2a and ribavirin, in chronic hepatitis C genotype-1 infected subjects who were null or partial responders to prior PegIFN? and ribavirin therapy. - NA
100 Clinical Results associated with Tibotec Pharmaceuticals
Login to view more data
Login to view more data
100 Deals associated with Tibotec Pharmaceuticals
Login to view more data
100 Translational Medicine associated with Tibotec Pharmaceuticals
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 07 Nov 2024
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
2
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free